Delivery Order SPE2DB25D3404-SPE2DB25FUNBD

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used to treat obesity. The contract has a ceiling value of $2,555.41 and a completion date of April 24, 2025. This award is not set-aside and is a firm fixed-price delivery order contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used to treat obesity. The award has a ceiling value of $2,975.70 and is a firm fixed-price delivery order contract with an ultimate completion date of April 24, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.25 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $37,356.40 and is a firm fixed-price delivery order with a completion date of November 15, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, valued at $4,089.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a Firm Fixed Price Delivery Order that runs through February 28, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 1 mg/0.5 mL pens, a medication used to treat obesity. The contract has a ceiling value of $2,726.36 and a period of performance through April 2025. It is a firm-fixed-price contract and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used in the treatment of obesity. The contract has a ceiling value of $3,842.83 and a completion date of December 19, 2023. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition....
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25 mg/0.5 ml Wegovy pens, a medication for the treatment of obesity. The contract has a ceiling value of $5,588.37 and runs through March 4, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a $12,285.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5 mg/0.5 ml Wegovy pens, a medication used in the treatment of obesity. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $7,935.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a prescription medication used for chronic weight management. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.25 mg/0.5 ml pens, a medication used to treat obesity. The contract has a firm fixed price of $4,095.00 and a period of performance through April 18, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUNBD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,403.14, is for the delivery of Wegovy 0.5 mg/0.5 ml pen 0.5ml, a medication used in the treatment of obesity.

The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is April 23, 2025. The contract is not set aside for any specific business type.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely a delivery order under that larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/22/25, 9:55 AM